[go: up one dir, main page]

ATE119197T1 - Schimäre immunkompromittierende säugetiere und ihre verwendung. - Google Patents

Schimäre immunkompromittierende säugetiere und ihre verwendung.

Info

Publication number
ATE119197T1
ATE119197T1 AT88312222T AT88312222T ATE119197T1 AT E119197 T1 ATE119197 T1 AT E119197T1 AT 88312222 T AT88312222 T AT 88312222T AT 88312222 T AT88312222 T AT 88312222T AT E119197 T1 ATE119197 T1 AT E119197T1
Authority
AT
Austria
Prior art keywords
tissue
xenogeneic
thymus
lymph node
cells
Prior art date
Application number
AT88312222T
Other languages
English (en)
Inventor
Joseph Mccrary Mccune
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22476130&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE119197(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE119197T1 publication Critical patent/ATE119197T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT88312222T 1987-12-23 1988-12-22 Schimäre immunkompromittierende säugetiere und ihre verwendung. ATE119197T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13717387A 1987-12-23 1987-12-23

Publications (1)

Publication Number Publication Date
ATE119197T1 true ATE119197T1 (de) 1995-03-15

Family

ID=22476130

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88312222T ATE119197T1 (de) 1987-12-23 1988-12-22 Schimäre immunkompromittierende säugetiere und ihre verwendung.

Country Status (8)

Country Link
EP (1) EP0322240B1 (de)
JP (1) JP2801228B2 (de)
AT (1) ATE119197T1 (de)
AU (1) AU2754888A (de)
DE (1) DE3853201T2 (de)
DK (1) DK720488A (de)
ES (1) ES2071620T3 (de)
IL (1) IL88779A (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
US6713610B1 (en) 1990-01-12 2004-03-30 Raju Kucherlapati Human antibodies derived from immunized xenomice
US6075181A (en) * 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
DK0463151T3 (da) * 1990-01-12 1996-07-01 Cell Genesys Inc Frembringelse af xenogene antistoffer
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5849288A (en) * 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
US5652373A (en) * 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
EP0438053B1 (de) * 1990-01-15 1999-06-16 Yeda Research And Development Company Limited Dauerhafte Verpflanzung und Entwicklung menschlicher hämatopoietischer Zellinien bei normalen Säugetieren
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5147784A (en) * 1990-04-12 1992-09-15 Systemix, Inc. T-lymphocyte progenitor cell assay
EP0481058B1 (de) * 1990-05-03 1996-07-17 Systemix, Inc. Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem
CA2064075A1 (en) * 1990-05-25 1991-11-26 Charles M. Baum Human peripheral blood cells in an immunocompromised host
DK9091D0 (da) * 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
US5858328A (en) * 1991-06-04 1999-01-12 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5804160A (en) * 1991-06-04 1998-09-08 Yeda Research And Development Co. Ltd Animal model for hepatitis virus infection
US5849987A (en) * 1992-06-02 1998-12-15 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
EP0539970B1 (de) * 1991-10-30 1999-05-26 Idemitsu Kosan Company Limited Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper
US6353150B1 (en) * 1991-11-22 2002-03-05 Hsc Research And Development Limited Partnership Chimeric mammals with human hematopoietic cells
NL9102122A (nl) * 1991-12-18 1993-07-16 Tno Werkwijze voor het testen van antivirale middelen; daarvoor bruikbare proefdieren.
US5866757A (en) * 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
WO1994016080A1 (en) * 1993-01-08 1994-07-21 Exemplar Corporation An in vitro/in vivo method for identifying anti-neoplastic drugs
GB9317766D0 (en) * 1993-08-26 1993-10-13 Agricultural & Food Res Animal models
US5985660A (en) * 1994-06-15 1999-11-16 Systemix, Inc. Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
US5972627A (en) * 1994-06-15 1999-10-26 Systemix, Inc. Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
WO1996001120A1 (en) * 1994-07-03 1996-01-18 P.N. Gerolymatos S.A. Thymus products and applications
US6455756B1 (en) 1994-08-12 2002-09-24 Novartis Ag Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
WO1996039811A1 (en) * 1995-06-07 1996-12-19 Novartis Ag Immunocompromised animals comprising human synovial tissue
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US5986170A (en) 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
CA2273194C (en) 1996-12-03 2011-02-01 Abgenix, Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
CA2284778A1 (en) 1997-03-26 1998-10-01 Jerome J. Strauss Endometriosis mouse model
CA2284689C (en) * 1997-04-09 2009-10-06 Lung-Ji Chang Animal model for evaluation of vaccines
EP1079688A1 (de) * 1998-05-26 2001-03-07 Innogenetics N.V. Verfahren zur expansion von primat b-zellen selektiv in immunitätsbeeinsträchtigten mäuse und produktion von hoher anzahl an antigenspezifische b-lymphozyten für die produktion von primat monoklonale antikörper
TW200813086A (en) 2006-05-11 2008-03-16 Hoffmann La Roche Immunereconstituted mouse
SG10201403703XA (en) * 2009-06-29 2014-10-30 Qingfeng Chen Methods of producing humanized non-human mammals
AU2010303737B2 (en) 2009-10-06 2014-05-29 Institute For Research In Biomedicine (Irb) Genetically modified mice and engraftment
KR102256316B1 (ko) 2011-02-15 2021-05-28 리제너론 파마슈티칼스 인코포레이티드 인간화된 ｍ－ｃｓｆ 마우스
DK2892330T3 (da) 2012-09-07 2023-01-30 Univ Yale Genetisk modificeret mus og fremgangsmåder til anvendelse deraf
EP3939423B1 (de) 2012-11-05 2024-03-06 Regeneron Pharmaceuticals, Inc. Genetisch modifizierte nagetiere und verfahren zur verwendung davon
IL312888A (en) 2014-05-19 2024-07-01 Regeneron Pharma Genetically modified non-human animals expressing human epo
FI3282835T3 (fi) 2015-04-13 2023-07-20 Regeneron Pharma Humanisoituja sirpa-il15-poistogeenisiä hiiriä ja niiden käyttömenetelmiä

Also Published As

Publication number Publication date
DE3853201T2 (de) 1995-09-14
AU2754888A (en) 1989-06-29
DK720488A (da) 1989-06-24
EP0322240A2 (de) 1989-06-28
IL88779A (en) 1995-07-31
JPH0231632A (ja) 1990-02-01
EP0322240B1 (de) 1995-03-01
DK720488D0 (da) 1988-12-23
ES2071620T3 (es) 1995-07-01
IL88779A0 (en) 1989-07-31
DE3853201D1 (de) 1995-04-06
JP2801228B2 (ja) 1998-09-21
EP0322240A3 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
ATE119197T1 (de) Schimäre immunkompromittierende säugetiere und ihre verwendung.
O'Donoghue et al. Fetal stem cells
Capel et al. Clonal contributions of small numbers of retrovirally marked hematopoietic stem cells engrafted in unirradiated neonatal W/Wv mice.
DE3262697D1 (en) Method for producing self-reproducing mammalian pancreatic islet-like structures
ATE253112T1 (de) Menschliche hematopoietische stammzellen
FI92258B (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
ATE142695T1 (de) Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
ATE139574T1 (de) Herstellung von proteinen mittels homologer rekombination
DK368786A (da) Fremgangsmaade til fremstilling af erythropoietin
EP1007630A4 (de) Natürliche killerzelllinien und verfahren zu ihrer verwendung
DK1019493T3 (da) Fremstilling af hæmatopoietiske celler fra multipotente neurale stamceller
NO890715D0 (no) Fremgangsmaate ved preservering av epitelsjikt dyrket in vitro.
DK42887A (da) Fremgangsmaade til fremstilling af et proteinkompleks med human faktor viii:c aktivitet ved rekombinant-teknik
Issarachai et al. Cells with hemopoietic potential residing in muscle are itinerant bone marrow–derived cells
ATE148502T1 (de) Verfahren, zubereitungen und anordnungen für zellzucht
CA2213322A1 (en) Thiols to promote hematopoietic progenitor cell growth
KR890700672A (ko) 혈소판과 관계된 생장조절제
EA199900507A1 (ru) Способы профилактики отторжения трансплантата при трансплантации и продуцирования универсальной клетки-хозяина для генной терапии
DE3061854D1 (en) Process for the preparation of interferon and culture medium composition used in it
AU6949994A (en) Animal model for hepatitis virus infection
ATE191501T1 (de) Verwendung von hepatocyten-wachstumsfaktoren zur herstellung eines vermehrungssystems für hematopoietische stammzellen
UA26870C2 (uk) Спосіб підвищеhhя продукуваhhя протеїhу с, спосіб підвищеhhя рівhя його модифікації
JPS6442468A (en) Substituted pyridylethanolamine, manufacture and use as livestock yield promoter
ES2151895T3 (es) Procedimiento para la obtencion de cultivos celulares con alto contenido en citoquinas endogenas.
Krishan et al. Chromosome studies of cell lines and tumors derived from a single specimen of human leukemic blood by cell culture and heterotransplantation

Legal Events

Date Code Title Description
RZN Patent revoked